Identifying the contribution of mTOR activity in cyclin D1 overexpression in mantle cell lymphomas highlighted the possible use of mTOR inhibitors (mTORIs) in lymphomas and other malignancies [266]. The gene discussed is MTOR; the disease is mantle cell lymphoma.